Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2021

Oct 6, 2021

35540_dirs_2021-10-06_363bab7b-590d-45dc-972a-5cebdd5dbb60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2021-10-04

Reporting Person: Barry James J (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-04 Stock Option (Right to Buy) $2.89 A 50000 Acquired 2031-10-04 Common Stock (50000) Direct

Footnotes

F1: 50% of the shares underlying this stock option vested and became exercisable immediately on the date of grant and 50% will vest and become exercisable on the first anniversary of the date of the director appointment on September 20, 2022, provided Dr. Barry is still serving as a director on such date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.